228 related articles for article (PubMed ID: 7886110)
1. Cocaine preexposure sensitizes conditioned fear in a potentiated acoustic startle paradigm.
Borowski TB; Kokkinidis L
Pharmacol Biochem Behav; 1994 Dec; 49(4):935-42. PubMed ID: 7886110
[TBL] [Abstract][Full Text] [Related]
2. Cocaine enhances the expression of fear-potentiated startle: evaluation of state-dependent extinction and the shock-sensitization of acoustic startle.
Willick ML; Kokkinidis L
Behav Neurosci; 1995 Oct; 109(5):929-38. PubMed ID: 8554716
[TBL] [Abstract][Full Text] [Related]
3. Lasting effect of repeated cocaine administration on acoustic and fear-potentiated startle in rats.
Gordon MK; Rosen JB
Psychopharmacology (Berl); 1999 May; 144(1):1-7. PubMed ID: 10379618
[TBL] [Abstract][Full Text] [Related]
4. The effects of cocaine, amphetamine, and the dopamine D1 receptor agonist SKF 38393 on fear extinction as measured with potentiated startle: implications for psychomotor stimulant psychosis.
Borowski TB; Kokkinidis L
Behav Neurosci; 1998 Aug; 112(4):952-65. PubMed ID: 9733202
[TBL] [Abstract][Full Text] [Related]
5. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.
Walker DL; Ressler KJ; Lu KT; Davis M
J Neurosci; 2002 Mar; 22(6):2343-51. PubMed ID: 11896173
[TBL] [Abstract][Full Text] [Related]
6. Involvement of pertussis toxin sensitive G-proteins in conditioned fear-potentiated startle: possible involvement of the amygdala.
Melia KR; Falls WA; Davis M
Brain Res; 1992 Jul; 584(1-2):141-8. PubMed ID: 1515934
[TBL] [Abstract][Full Text] [Related]
7. Acute withdrawal from repeated cocaine treatment enhances latent inhibition of a conditioned fear response.
Murphy CA; Heidbreder C; Feldon J
Behav Pharmacol; 2001 Feb; 12(1):13-23. PubMed ID: 11270508
[TBL] [Abstract][Full Text] [Related]
8. Fear-potentiated startle and light-enhanced startle models in drug discovery.
Groenink L; Bijlsma EY; Olivier B
Curr Protoc Pharmacol; 2008 Jun; Chapter 5():Unit5.48. PubMed ID: 22294228
[TBL] [Abstract][Full Text] [Related]
9. Extract of Ginkgo biloba EGb761 facilitates extinction of conditioned fear measured by fear-potentiated startle.
Yang YL; Su YW; Ng MC; Chao PK; Tung LC; Lu KT
Neuropsychopharmacology; 2007 Feb; 32(2):332-42. PubMed ID: 16554745
[TBL] [Abstract][Full Text] [Related]
10. Conditioned fear and startle magnitude: effects of different footshock or backshock intensities used in training.
Davis M; Astrachan DI
J Exp Psychol Anim Behav Process; 1978 Apr; 4(2):95-103. PubMed ID: 670892
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological analysis of fear-potentiated startle.
Davis M
Braz J Med Biol Res; 1993 Mar; 26(3):235-60. PubMed ID: 8257926
[TBL] [Abstract][Full Text] [Related]
12. Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear.
Yang YL; Chao PK; Lu KT
Neuropsychopharmacology; 2006 May; 31(5):912-24. PubMed ID: 16205786
[TBL] [Abstract][Full Text] [Related]
13. Treatment with a heat-killed preparation of Mycobacterium vaccae after fear conditioning enhances fear extinction in the fear-potentiated startle paradigm.
Hassell JE; Fox JH; Arnold MR; Siebler PH; Lieb MW; Schmidt D; Spratt EJ; Smith TM; Nguyen KT; Gates CA; Holmes KS; Schnabel KS; Loupy KM; Erber M; Lowry CA
Brain Behav Immun; 2019 Oct; 81():151-160. PubMed ID: 31175996
[TBL] [Abstract][Full Text] [Related]
14. Fear-potentiated startle using an auditory conditioned stimulus: effect of lesions of the amygdala.
Hitchcock JM; Davis M
Physiol Behav; 1987; 39(3):403-8. PubMed ID: 3575483
[TBL] [Abstract][Full Text] [Related]
15. Lesions of the perirhinal cortex but not of the frontal, medial prefrontal, visual, or insular cortex block fear-potentiated startle using a visual conditioned stimulus.
Rosen JB; Hitchcock JM; Miserendino MJ; Falls WA; Campeau S; Davis M
J Neurosci; 1992 Dec; 12(12):4624-33. PubMed ID: 1464761
[TBL] [Abstract][Full Text] [Related]
16. Effects of oxytocin on background anxiety in rats with high or low baseline startle.
Ayers L; Agostini A; Schulkin J; Rosen JB
Psychopharmacology (Berl); 2016 Jun; 233(11):2165-2172. PubMed ID: 27004789
[TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated protein kinase cascade in the basolateral nucleus of amygdala is involved in extinction of fear-potentiated startle.
Lu KT; Walker DL; Davis M
J Neurosci; 2001 Aug; 21(16):RC162. PubMed ID: 11473133
[TBL] [Abstract][Full Text] [Related]
18. Temporary inactivation of the perirhinal cortex by muscimol injections block acquisition and expression of fear-potentiated startle.
Schulz B; Fendt M; Richardson R; Schnitzler HU
Eur J Neurosci; 2004 Feb; 19(3):713-20. PubMed ID: 14984422
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear-potentiated startle.
Greba Q; Gifkins A; Kokkinidis L
Brain Res; 2001 Apr; 899(1-2):218-26. PubMed ID: 11311883
[TBL] [Abstract][Full Text] [Related]
20. Acoustic startle and fear-potentiated startle in alcohol-preferring (P) and -nonpreferring (NP) lines of rats.
Mckinzie DL; Sajdyk TJ; Mcbride WJ; Murphy JM; Lumeng L; Li TK; Shekhar A
Pharmacol Biochem Behav; 2000 Apr; 65(4):691-6. PubMed ID: 10764924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
